Septerna Stock Explodes After Billion-Dollar Deal With Novo Nordisk
Reading Time: 3 minutes
The stock of the US biotechnology company Septerna (NASDAQ: SEPN) experienced a spectacular price jump on Wednesday, May 15. Following the announcement of a far-reaching research and development collaboration with the Danish pharmaceutical company Novo Nordisk (NYSE: NVO), the stock surged by approximately 50% during regular trading. The background is a strategic agreement with a potential total value of up to $2.2 billion. Notably, even after the price jump, Septerna's market capitalization remains below $500 million. Strategic partnership in...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
